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INTRODUCTION 
  
 Epilepsy has been one of the most common problems faced by neurologists 
worldwide. It is a condition where a person can have recurrent seizures because of a 
chronic, underlying process1. Though well known and existing for more than 2000 
years, it is only in recent years that epilepsy has got  the attention of medical 
community.   
 In industrialized countries, specific etiology has been recorded in about 60-
70% of cases of epilepsy. But in developing countries despite the abundance of 
potential causes of epilepsy, a known etiology has been reported in less than 40% of 
cases only2. 
 The distribution of epilepsy varies among sociodemographic and economic 
groups with higher rates reported in male gender, rural population, and low 
socioeconomic status.  A changing trend is observed in age specific occurrence of 
epilepsy with a preponderance towards older age group. 
 The profile of epilepsy also varies across different cultures, and literature 
shows that in western countries about two-third of the cases are partial seizures3. On 
the contrary, Indian studies report a reverse trend where generalized seizures 
constitute more than 70% of all seizures4. The lower frequency of partial seizures in 
developing countries is attributed to the fact that they may be underreported in studies 
that use inadequate screening questionnaires5.  
  
 
  
 The etiology of seizures is directly linked to the type of the seizure6. In case of 
partial seizures, localisation of abnormalities is from 28% to 80% as observed in 
various studies. A proper history is essential to identify the type of seizure. Since 
focal seizures are more often associated with focal cerebral lesions, successful 
treatment of patients depends on identifying the cause and proper treatment thereby 
reducing morbidity and mortality.  
 Hence, this study is done to evaluate the clinical profile and etiology of new 
onset focal seizures in patients aged more than 12 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
AIM OF THE STUDY 
 
1. To study the clinical profile of focal seizures 
2. To evaluate the etiological profile of focal seizures 
 
 
 
 
 
 
 
 
 
 
  
  
 
REVIEW OF LITERATURE 
HISTORICAL OVERVIEW: 
 Seizures was first mentioned in ancient Akkadian texts, the Sakkiku around 
2000 BC which used the terms 'antasubba' and 'miqtu' for describing seizures7. 
Epilepsy was also described in texts from ancient Babylonians where patients with 
epilepsy were considered to be affected by evil spirits. Indian texts described epilepsy 
with premonitory symptoms and loss of memories as 'Abasmara'. Until around 200 
years before, epilepsy was considered to be a disorder of supernatural origin due to 
demonic possession.  
 The first hallmarks in the history of epilepsy are the Hippocratic texts from 
fifth century B.C. which questioned the divine origin of the disease. Hippocrates gave 
an alternate thought that epilepsy is an ordinary medical condition with a natural 
cause8.  
 John Hughlings Jackson, a British neurologist, considered the father of modern 
epileptology was the first one who studied epilepsy based on anatomy and pathology9. 
He reported that convulsions occurred due to a discharging lesion from damage to 
nerve cells and correlated the ictal behaviour with brain anatomy. 
 The description about partial seizure was first described by Bravais in 1827, by 
Jackson in 1860s and by Charcot as partial seizures in 1870s. Charcot called them 
Bravais-Jackson seizures. Though Bravais was the first to describe this type of seizure 
where convulsions was restricted to one side of the body which he called 'hemiplegic 
seizures', Jackson took this to a higher level and reasoned out that there should be a 
localized representation for this in cerebral cortex based on clinicopathologic 
  
correlations10. Fritsch and Hitzig confirmed this experimentally in dogs when 
electrical stimulation of motor cortex gave rise to focal muscular contractions11. 
 The human Electroencephalogram (EEG) discovered by the German 
Psychiatrist Hans Berger in 1929 made clear the presence of electrical discharges in 
brain and localisation of the site of epileptic discharges to certain extent12.  EEG plays 
an important role in diagnosing and managing seizure disorders in addition to the 
various imaging techniques developed over the last 30 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
EPIDEMIOLOGY 
INCIDENCE: 
 According to the World Health Organization (WHO), there are 50 million 
people with epilepsy worldwide13. 80% of them reside in developing countries. 
Epilepsy was estimated to constitute 0.5% of the global burden of disease14. 
There is regional variation in incidence of epilepsy worldwide. Incidence is 
high in Africa and Latin America where it exceeds 100 per 1,00,00015. Among the 
few studies conducted in developing countries, two studies done in Mariana Islands 
have reported an annual incidence of 30-47.3 per 100 000 population16,17.Partial 
seizures were found to constitute around 60% of seizures in developed countries18. In 
developing countries the incidence was relatively higher around 80%, which could be 
attributed to the higher rate of CNS infections19. 
 
PREVALENCE: 
 Prevalence is the measure of total number of persons with epilepsy at a specific 
moment of time. It is expressed as the number of persons with epilepsy per 1000 
population. The prevalence of epilepsy in industrialized countries is found to be about 
3-9 per 1000 population. Several African and Latin American countries showed 
prevalence more than 3-9 per 100020. 
  
 
In a study in the United Republic of Tanzania, a Bantu population showed a 
prevalence of 20 per 1000 with a family history of epilepsy in 76.6% which supported 
  
a strong genetic basis in this tribe21,22. The prevalence of epilepsy was also found to 
increase with age in many studies, reaching a peak in the third and fourth decades of 
life. In some studies in Ethiopia, Nigeria, and Sri Lanka the highest rates occurred in 
the second decade of life23. 
 In India, there are more than 10 million people with epilepsy constituting a 
prevalence of 1%24. Rural population make up a prevalence of 1.9% while urban 
population constitutes only 0.6%25,26.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
DEFINITION 
SEIZURES:1 
A Seizure is a paroxysmal event due to abnormal excessive hypersynchronous 
neuronal activity in the brain.  
 
EPILEPSY: 
Epilepsy is a clinical phenomenon characterised by atleast two unprovoked 
seizures separated by a minimum duration of 24 hours. The word epilepsy comes 
from a Greek word meaning "to seize upon" or "taking a hold of". 
 
OPERATIONAL CLINICAL DEFINITION OF EPILEPSY:27 
Epilepsy is defined by any of the following: 
1. At least two unprovoked seizures occurring >24 h apart 
 2. One unprovoked seizure and a probability of further seizures similar to the general 
recurrence risk (at least 60%) after two unprovoked seizures, occurring over the 
next 10 years  
3. Diagnosis of an epilepsy syndrome  
 
Epilepsy is considered resolved for those with an age-dependent epilepsy 
syndrome but who are now past the applicable age or when seizure-free for the last 10 
years, without antiepileptic drugs for the last 5 years. 
 
 
 
 
  
CLASSIFICATION OF SEIZURES: 
   Seizures can be classified as: 
1) Based on etiology – primary (idiopathic) or secondary (symptomatic) 
2) Based on site of origin – generalised or focal 
3) Based on their frequency – isolated, cyclic or repetitive 
 
INTERNATIONAL LEAGUE AGAINST EPILEPSY (ILAE) 
CLASSIFICATION OF EPILEPTIC SEIZURES, 198128 
I. PARTIAL (FOCAL) SEIZURES 
 A. Simple partial seizures 
 B. Complex partial seizures 
 C. Partial seizures evolving to secondarily generalized seizures 
II. GENERALIZED SEIZURES 
 A. Absence seizures 
 B. Myoclonic seizures 
 C. Clonic seizures 
 D. Tonic seizures 
 E. Tonic-Clonic seizures 
 F. Atonic seizures 
III. UNCLASSIFIED EPILEPTIC SEIZURES 
 
 
  
ILAE’s CLASSIFICATION OF EPILEPSIES AND EPILEPTIC 
SYNDROMES: 
 Epileptic syndromes include constellations of epileptic seizures and concurrent 
or serially linked symptoms and signs. Epilepsies and epileptic syndromes are 
classified according to localisation into focal or generalized, which are in turn 
classified into idiopathic, symptomatic and cryptogenic (unclassified/mixed) 
syndromes. 
1. Idiopathic epilepsy syndromes (focal or generalised) 
a. Benign neonatal convulsions 
i. Familial 
ii. Nonfamilial  
b. Benign childhood epilepsy 
i. With central midtemporal spikes 
ii. With occipital spikes 
c. Childhood /juvenile absence epilepsy 
d. Juvenile myoclonic epilepsy 
e. Idiopathic, otherwise unspecified 
2. Symptomatic epilepsy syndromes (focal or generalised) 
a. West syndrome 
b. Lennox gastaut syndrome 
  
c. Early myoclonic encephalopathy 
d. Epilepsia partialis continua 
e. Acquired epileptic aphasia 
f. Temporal lobe epilepsy 
g. Frontal lobe epilepsy 
h. Post traumatic epilepsy 
i. Other symptomatic epilepsy  
3. Other epilepsy syndrome of uncertain or mixed classification 
a. Neonatal seizures 
b. Febrile seizures 
c. Reflex seizures 
d. Other unspecified 
FOCAL SEIZURES:  
 The definition of focal seizures is updated as "originating within networks 
limited to one hemisphere". Though the origin may be broadly distributed, it is still 
confined to one hemisphere. Only limited cases of focal seizures can be localised 
based on clinical data alone. Along with scalp and intracranial EEG recording and 
MRI, the localization can be done reasonably accurately.  
 The ILAE Commission on Classification and Terminology, 2005-2009 has 
provided an updated approach to classification of seizures, where the term partial 
  
seizures has been replaced by focal seizures. The term simple partial seizures and 
complex partial seizures are eliminated and focal seizures are classified as: 
1. Focal seizures without dyscognitive features 
2. Focal seizures with dyscognitive features 
3. Focal seizures evolving into generalized seizures 
 
FOCAL SEIZURES WITHOUT DYSCOGNITIVE FEATURES 
 Focal seizures without dyscognitive features, previously referred as Simple 
Partial Seizures is a type of focal seizure where the consciousness is not impaired. 
This is divided into four major categories: 
1. With motor symptoms 
2. With somatosensory or special sensory symptoms.  
3. With autonomic symptoms or signs 
4. With psychic symptoms 
 
Focal motor seizures 
 The hallmark of focal motor seizures is focal motor activity which may be 
expressed as clonic, tonic, postural or phonatory activity. This type of seizure arises 
due to a focal discharging lesion in frontal lobe. The most common type arises from 
the supplementary motor area. This usually manifests as turning movement of the 
head and eyes to the side opposite the irritative lesion, mostly associated with tonic 
extension of limbs. This forceful sustained deviation of the head and eyes, sometimes 
with entire body is referred as versive seizures.  Usually this occurs opposite to the 
side of irritative focus29. 
  
 The characteristic features which may be seen in focal motor seizures are the 
abnormal motor movements which may begin in fingers and gradually progress to 
involve other areas. This phenomenon was described by Hughlings Jackson and 
known as Jacksonian march. Patients may also develop localized paresis involving the 
region for minutes to many hours which is known as Todd's paralysis. In rare 
instances, focal motor seizures may continue for hours to days and individual jerks 
occur no more than 10 seconds apart which is termed "epilepsia partialis continua", 
which may be refractory to medical therapy30. This usually occurs due to lesions 
involving the sensorimotor cortex due to stroke, tumor, trauma or metastasis31.   
 The high incidence of movements involving hands, face and toes is probably 
due to disproportionately large representation of these parts in the cortex. The focus of 
excitation is at or near the motor cortex, Brodmann area 4. If there is associated 
sensory symptom, postrolandic area may also be involved. Lesions confined to the 
motor cortex are associated with clonic contractions while those confined to premotor 
cortex are associated with tonic contractions of limbs. Dystonic and choreoathetotic 
posturing are found in medial frontal lesions. Brief aphasic disturbance termed ictal 
aphasia may be seen when seizure discharges also involves language areas of cortex. 
 
Focal sensory seizures 
 Focal sensory seizures were defined by Penfield and Jasper separately from 
autonomic and psychic symptoms32 and they classified these sensory seizures as33 
 Somatosensory 
 Visual 
 Auditory 
  
 Olfactory 
 Gustatory 
 Vertiginous 
Somatosensory: This usually presents as numbness, tingling, or pins-and-needles 
feeling and sometimes as crawling sensation. This may be focal or a marching 
sensation may occur from one part to other. The discharge usually occurs from the 
postcentral gyrus and in majority, onset occurs in lips, fingers or toes. Peculiar body 
sensations may occur from discharges in supplementary motor area. 
Visual seizures are relatively rare but can be localized to striate cortex of occipital 
lobe. They may present as flashing lights, darkness or sparks, colorless or may be 
colored, may be stationary or moving. The most commonly reported colour was found 
to be red followed by blue, green and yellow34. While elementary visual 
hallucinations and visual loss are characteristic of occipital lobe epilepsy35, more 
complex and formed hallucinations are features of temporal lobe lesions.  
Auditory seizures are infrequent and if present are described as buzzing or drumming 
or a roaring sound in ears and are mapped to lesions in superior temporal convolution. 
Auditory hallucinations usually represent a psychotic disorder.  
Olfactory seizures, called uncinate fits presents with an aura of disagreeable odour 
and the localization is invariably in the inferior or medial parts of temporal lobe 
involving the uncinate gyrus.  
Gustatory hallucinations are seen in cases of temporal lobe diseases; may be 
associated with salivation and thirst sensation. 
Vertiginous sensations described as dizziness or unsteadiness may on rare occasions 
present as a first symptom of seizure. Though the lesion may be localized to 
  
superoposterior temporal region, this symptom has many different connotations and 
often is of little diagnostic value. 
 
Focal autonomic seizures 
 Autonomic phenomena constitute around one third of partial seizure 
symptoms. 30% of simple partial seizures were classified as autonomic in a study 
conducted by Devinsky et al, out of which 33% was associated with motor seizures36. 
The most common autonomic manifestation described is abdominal sensations 
particularly in mesial temporal lobe epilepsy37. This is described as a rising sensation 
from epigastrium and may be associated with nausea, fear, pain and hunger. Ictal 
vomiting may be seen when discharges arise from opercular region which may be 
frequently misdiagnosed as an organic gastrointestinal disorder38. Abdominal pain 
may occur as the sole manifestation of seizures in children.  
 Palpitations and chest pain are the next common autonomic symptoms, usually 
associated with sinus tachycardia. Other symptoms like perspiration, urinary urgency 
or incontinence, flushing, cyanosis, lacrimation, hyperventilation may be seen. 
Genital symptoms like erotic feelings and orgasm are infrequent.  
 
Psychic seizures39 
Psychic symptoms may be perceptual hallucinations/illusions in the form of visual, 
auditory or olfactory; Odd internal feelings such as deja vu or jamais vu; Emotional 
changes like fear, sadness, pleasure, sexual arousal or anger. Cognitive changes like 
changes in reality and depersonalization or forced thinking may be associated. 
Psychic seizures are predominantly found in mesial temporal lobe epilepsy. 
  
FOCAL SEIZURES WITH DYSCOGNITIVE FEATURES 
 Focal seizures with dyscognitive features, previously referred as Complex 
Partial Seizures is a type of focal seizure with impairment of consciousness 
The seizures mostly begin with an aura which is stereotypic for the patient. The ictal 
phase often starts with a sudden behavioural arrest or motionless stare, which marks 
the onset of the period of impaired awareness. The behavioural arrest is frequently 
accompanied by automatisms, which are involuntary， automatic behaviours with a 
wide range of manifestations. Automatisms may present as very basic behaviours 
such as chewing, lip smacking, swallowing， or "picking" movements of the hands, 
or more elaborate behaviours such as an emotional display or running. The seizure is 
typically followed by post ictal confusion with transition to a fully conscious state 
occurring after a few seconds to an hour. The seizures most commonly arise from the 
temporal lobe followed by frontal lobe.  
 
FOCAL SEIZURES EVOLVING INTO GENERALIZED SEIZURES 
 These seizures may start as focal seizures with or without impairment of 
consciousness. The transition to secondary generalization usually involves versive 
head turning in a direction contralateral to the hemisphere of seizure onset and focal 
or lateralized tonic or clonic motor activity40. The generalized tonic phase is 
asymmetrical with flexion on one side and extension on the other. This has been 
named as figure of 4 posturing41. There is gradual evolution from tonic to clonic 
activity with a tremulous or vibratory phase with high frequency tremors. Clonic 
activity then decreases over time with longer intervals between jerks. Once the clonic 
  
activity stops, the individual becomes limp with a loud snoring referred as stertorous 
respiration. 
AURA:42 
 The term aura was introduced by Galen. Aura is a purely subjective sensation 
which is of short duration lasting for few seconds to few minutes. In case of simple 
partial seizures, the aura may constitute the entire seizure while it may be the initial 
symptom followed by loss of consciousness in a complex partial seizure. 
 
Aura symptoms can be categorized as:43 
 Epigastric auras 
 Autonomic auras 
 Emotional auras 
 Vestibular auras 
 Psychic auras 
 Visual auras 
 Somatosensory auras 
 Dysphasic auras 
 Olfactory auras 
 Auditory auras 
 Whole body sensations 
 Cephalic sensations 
 Uncategorized 
 
 
  
COMMON FOCAL SEIZURE PATTERNS 
 
TYPE OF SEIZURE     LOCALIZATION 
SOMATIC MOTOR 
Jacksonian(focal motor)     Prerolandic gyrus 
Masticatory, salivation, speech arrest   Amygdaloid nuclei 
Head and eye turning with arm movements  Supplementary motor cortex 
SOMATIC AND SPECIAL SENSORY 
Somatosensory      Contralateral postrolandic 
Unformed images, lights, patterns    Occipital 
Auditory       Heschl gyri 
Vertiginous        Superior temporal 
Olfactory       Mesial temporal 
Gustatory       Insula 
Visceral       Insular, Orbitofrontal cortex 
FOCAL SEIZURES WITH DYSCOGNITIVE FEATURES 
Formed hallucinations     Temporal neocortex or  
       amygdala, hippocampus 
Affective states      Temporal 
Automatism       Temporal and frontal 
 
 
 
 
  
SYNDROMES ASSOCIATED WITH FOCAL SEIZURES 
 
BENIGN FOCAL EPILEPSY OF CHILDHOOD: 
 Benign Epilepsy with centrotemporal spikes, Rolandic Epilepsy 
 This is the most common epileptic syndrome in children. Usual age of onset is 
between 5 and 9 years. This constitutes 15 to 25% of childhood epilepsies. Genetic 
factors play a role with autosomal dominant inheritance with variable penetrance.  
Presents as focal onset, nocturnal, tonic clonic seizures involving one side of face; 
less often one arm or leg may be involved. The diagnosis depends on clinical 
presentation and EEG. The typical EEG abnormality is central mid temporal blunt 
sharp waves activated in sleep. Seizures are readily controlled with a single 
antiepileptic drug and self limiting gradually disappearing during adolescence.  
 
RASMUSSEN SYNDROME: 
 This is characterized by intractable focal motor seizures with frequent episodes 
of focal status or epilepsia partialis continua on one side of the body. Usually children 
affected are between 6 and 10 years of age. The disease progression leads to 
hemiplegia and focal brain atrophy.  The disease is associated with intellectual decline 
and behavioural disturbances. An autoimmune hypothesis is postulated with the 
presence of autoantibodies to Glutamate receptor 3(GluR3). Imaging shows 
progressive hemiatrophy.  The seizures are usually refractory to medical therapy. The 
use of high dose corticosteroids have proved beneficial in some cases when started 
early within the first year of the disease. Hemispherectomy is considered for 
refractory seizures when the disease is extensive and unilateral.  
  
 
 
FAMILIAL MESIAL TEMPORAL LOBE EPILEPSY: 
 Familial MTLE is a benign condition, first identified in twins. The most 
prominent aura is déjà vu with frequent focal seizures without dyscognitive features, 
infrequent focal seizures with dyscognitive features and rare secondarily generalized 
seizures. Prior history of febrile seizures are uncommon and MRI is normal with no 
hippocampal sclerosis. This is very responsive to medical treatment. Familial MTLE 
is probably polygenic in inheritance, although no gene mutation has been identified so 
far.   
 
 
 
MESIAL TEMPORAL LOBE EPILEPSY: 
 The seizures are typically focal seizures with dyscognitive features with aura 
and automatisms. The most common aura is an epigastric sensation. Most common 
presentation is in early childhood or late adolescence. Patients usually have a history 
of antecedent complex febrile seizures in upto 80%44. The febrile seizures are usually 
complex and prolonged. Memory impairment is present with longer duration of 
seizures. MRI shows hippocampal sclerosis with decreased volume and increased 
signal. Seizures are refractory to medical therapy with excellent response to surgery. 
60 to 80% of patients become seizure free after temporal lobectomy. 
 
 
 
  
 
PANAYIOTOPOULOS SYNDROME 
 This syndrome presents as focal seizures with dyscognitive features 
predominantly with autonomic manifestations mainly ictal vomiting, altered 
responsiveness and deviation of eyes to one side. Onset is between 1 and 14 years of 
age with a peak at 4 to 5 years. Seizures predominate during sleep. EEG shows 
multifocal spikes with posterior predominance. Though the seizures may be alarming, 
they are infrequent and associated with good prognosis. Remission usually occurs in 1 
to 3 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ETIOLOGY OF SEIZURES ACCORDING TO THE AGE GROUP 
NEONATES:  Perinatal hypoxia 
   Developmental disorders 
   Genetic disorders 
   Acute CNS infection 
   Intracranial haemorrhage and trauma 
   Hypoglycemia, hypocalcemia, hypomagnesemia 
   Pyridoxine deficiency, biotinidase deficiency 
   Drug withdrawal 
INFANTS AND CHILDREN: 
   Genetic disorders 
   Developmental abnormalities 
   Febrile seizures 
   Trauma 
   CNS infection 
   Idiopathic 
 
ADOLESCENCE (12-18YEARS): 
   Genetic disorders 
   CNS infection 
   Trauma 
   Tumour 
   Illicit drug abuse 
   Idiopathic 
  
YOUNG ADULTS (18-35 YEARS): 
   Trauma 
   Tumour 
   Illicit drug abuse 
   Alcohol withdrawal 
   Idiopathic 
OLDER ADULTS (>35YEARS): 
   Alcohol withdrawal 
   CNS infections 
   Cerebrovascular diseases 
   Metabolic disorders (uremia, hypoglycemia,  
Hyperglycemia, hyponatremia, hepatic failure) 
   Degenerative disorders 
Tumour  
Drug induced 
Idiopathic 
 
MECHANISMS OF SEIZURES: 
 Focal seizures begin in a very discrete region of cerebral cortex. The burst 
activity in the neurons causing the seizure occurs due to a relatively long lasting 
depolarization of the neuronal membrane due to calcium influx intracellularly, which 
leads to opening of voltage dependent sodium channels resulting in influx of sodium 
and generation of action potentials repetitively. This is followed by a 
hyperpolarization mediated by GABA or K+ channels. 
  
When the focal seizure activity spreads slowly into the surrounding regions, 
there is recruitment of surrounding neurons with sufficient activation which leads to 
propagation of currents into adjacent areas.  
 
The recruitment of neurons occurs by various mechanisms like: 
1) Blunting of hyperpolarisation because of increase in extracellular potassium 
(K+) 
2) Calcium accumulation in presynaptic terminals causing release of 
neurotransmitters 
3) Activation of N-methyl-D-aspartate receptor which results in further 
calcium influx 
4) Changes in tissue osmolarity and swelling of neuronal cells. 
 
FACTORS INFLEUNCING THE NEURONAL EXCITABILITY: 
1) Changes in ionic channel conductance 
2) Second messengers 
3)  Cytoplasmic buffering 
4) Response of receptors over neuronal membrane 
5) Expression of proteins by genetic mechanisms 
6) Changes in the neurotransmitter levels 
7) Modulation of neuronal receptors 
  
 
MECHANISM OF EPILEPTOGENESIS: 
 In epilepsy, a normal neuronal network is transformed to one that is 
chronically hyperexcitable. This occurs after a delay of months or years following an 
injury in the form of stroke, infection and trauma. The neurons of these epileptic 
focuses become susceptible to various stimuli like hypoxia, hypoglycaemia, 
hyperthermia, hyponatremia, hypocalcemia etc., Biochemical studies reveal following 
abnormalities. 
1)  Increased levels of extracellular potassium in the glial scars 
2)  Defects in calcium channel. 
3) Deficiency in the neurotransmitter GABA 
4) Increased glycine 
5) Decreased taurine 
6) Increase or decrease in glutamic acid. 
PATHOLOGY OF EPILEPSY: 
 Pathological examination of autopsied specimen in most patients of primary 
generalised epilepsy show normal findings and also in cases where seizure occurs 
secondary to electrolyte disturbances, drug withdrawal, and drug intoxication since 
the primary defect is at the cellular level and neurotransmitters. Morphological 
changes like neuronal loss, gliosis, tumors, vascular malformations, hamartoma, 
heterotopias are noted in symptomatic epilepsies.  In case of temporal lobe epilepsy, 
  
pathological examination showed specific loss of neurons in the hippocampus and 
amygdala, distortion and loss of dendritic spines, and disruption of neuronal cells.   
ROLE OF GENETICS: 
  Genetic studies show the presence of various gene mutations in association 
with epileptic syndromes. Single gene disorders account for 1-2% of all epilepsies and 
they present with additional neurological and systemic manifestations. Single gene 
disorders leading to pure epilepsy are rare conditions which are due to mutations 
involving ionic channels. Following are few such disorders, 
1) Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) 
2) Benign familial neonatal convulsions (BFNC) 
3) Generalised epilepsy with febrile seizures plus (GEFS+) 
4) Progressive myoclonus epilepsy (PME) 
5) Dravet’s syndrome 
In addition to single gene disorders, epilepsy may be a part of various chromosomal 
and other genetic disorders like Down’s syndrome, Angelman’s syndrome, fragile X 
syndrome, glycogen storage disorders, aminoacid disorders, mitochondrial disorders, 
neurocutaneous disorders, and neurodegenerative disorders. 
 
HISTORY AND EXAMINATION: 
 Evaluation of a patient presenting with focal seizures first involves detailed 
history of the onset and evolution of seizures and associated symptoms like presence 
of an aura, automatism, postictal features and postictal deficits. Patients should be 
  
specifically asked for the presence of sensory symptoms and psychic auras.  They are 
useful in localizing the seizure and etiology in many cases.  The various risk factors 
and predisposing factors should be explored. The stereotypic nature of a seizure may 
be helpful in confirming a diagnosis of epilepsy. History of trauma, infections, 
tumour, stroke, systemic diseases, alcohol and drug abuse should be obtained. 
Identification of certain specific risk factors can help in prediction of the 
epileptogenic lesion. A history of febrile status epilepticus in infancy is associated 
strongly with hippocampal sclerosis45. Meningitis and encephalitis prior to age 5 is 
also associated with hippocampal sclerosis and temporal lobe epilepsy. Similarly, 
hippocampal sclerosis may also occur after head trauma.   
 Physical examination is done to identify neurocutaneous markers, signs of 
systemic illness or infection. Complete neurological examination should be done to 
assess memory status. Other system examinations are also carried out to rule out any 
organomegaly, evidences for chronic liver diseases, chronic renal diseases, and heart 
diseases. 
 
 
LABORATORY EVALUATION: 
 Laboratory studies like complete blood count, blood sugar, renal function tests, 
liver function tests, electrolytes, thyroid function tests, and toxin screening in urine 
and blood should be done. 
 Lumbar puncture is done in those patients presenting with fever and signs of 
infection in whom meningitis or encephalitis are suspected. It is also indicated in 
cases of persistent alteration in mental status, elevated white blood cell count, and in 
  
the absence of a precipitating factor. Lumbar puncture is particularly useful in cases 
of subarachnoid haemorrhage if CT brain is negative. CSF obtained through lumbar 
puncture should be sent for biochemical analysis, cytological analysis, cultures, PCR, 
and serological studies.  
 
ELECTROPHYSIOLOGICAL STUDIES: 
  After initial examination and evaluation, a routine electroencephalography is 
the most commonly used neurodiagnostic test for evaluation of seizures since it is 
more informative to detect seizure activity. The absence of electrical activity does not 
exclude the diagnosis of seizure disorder because focal seizures arise from discrete 
areas of cortex which may not be detected by standard scalp electrodes. The detection 
of interictal spikes by scalp electrodes depends on the extent of epileptogenic zone. A 
6 cm2 critical area has to be involved to detect changes at the scalp electrodes. 
  It is not always possible to take ictal EEG, hence continuous monitoring by 
means of video EEG for prolonged duration can be obtained. About 50% of patients 
with epilepsy are found to show epileptic discharges in the first interictal EEG. Yield 
can be increased by the use of sleep studies46. The combination of sleep and wake 
records gives a yield of 80% in patients with clinically confirmed epilepsy. Yield can 
also be increased by the use of several special EEG procedures such as 
hyperventilation and photic stroboscopic stimulation.  
 The National Institute for Clinical Excellence guidelines for diagnosis and 
management of epilepsies in adults and children recommends an EEG to support a 
diagnosis of epilepsy in adults in whom history suggests epileptic seizures47. In 
  
children, EEG is recommended after second or subsequent seizure. For those 
requiring an EEG, it should be performed within 4 weeks of request.  
 The EEG can also help determine prognosis after a first seizure. An abnormal 
EEG is consistently associated with an increased risk of recurrence of seizure. Video 
EEG monitoring is indicated for patients who continue to have seizures inspite of 
adequate treatment as the possibility of incorrect seizure diagnosis has to be ruled out.   
 
 
IMAGING STUDIES: 
 Imaging plays an important role in focal seizures to localize the origin of focal 
seizures and to identify its cause which guides the treatment and prognosis of the 
patient. If a lesion is shown in a patient with seizures then there is high probability 
that seizures are due to that lesion48. According to guidelines given by American 
Academy of Neurology (1996), CT brain should be taken in new onset seizures in 
adults for acute emergency management49.  
 Though CT brain remains the test most likely to be taken in the emergency 
room, MRI brain is more sensitive and is the imaging modality of choice. It is 
invaluable in identifying the cause of focal seizures, especially in seizures of temporal 
lobe origin as inferior temporal lobe lesions may not be seen even with contrast 
enhanced CT scan due to the beam hardening artefacts50. Physiologic imaging with 
SPECT and PET provides findings complementary to MRI but the physiologic 
changes are more widespread and less specific than MRI and EEG51. 
CAUSES OF FOCAL SEIZURES 
STROKE: 
  
 Stroke is the most common cause of seizures in the elderly. Post stroke 
seizures are of two types. They can be early onset or late onset based on the 
occurrence of seizures after stroke. Early onset seizures occur within two weeks of 
stroke and late onset seizures occur after two weeks. In a multicentre prospective 
study, seizures were found in 8.9% of stroke patients. Of the post stroke seizures, 
10.6% were due to hemorrhagic stroke, and 8.6% were due to ischemic stroke52. Risk 
of chronic epilepsy is highest in the first year after stroke. Approximately 30% of 
individuals who have early poststroke seizures develop epilepsy. 
 The incidence of seizures depends upon the type of stroke, the location of 
lesion and the severity of stroke. Seizures are more common in large haemorrhages 
involving cerebral cortex and less common in deep hematoma and supratentorial 
haemorrhage. The early onset post stroke seizures arise from the epileptic discharges 
of neurons in penumbra surrounding the central core of dead neurons whereas late 
onset post stroke seizures arise from the epileptic focus secondary to structural brain 
abnormalities53. 
In CVT, 40% of patients have seizures at the time of presentation of disease 
and 6.9% of patients develop seizures within 2 weeks of onset of illness54. Risk of 
developing seizures depends on the location of thrombosis and the associated 
parenchymal lesion54. 
 
METABOLIC ABNORMALITIES: 
The metabolic and electrolyte abnormalities causing the seizures of adults 
include hypoglycemia, hyperglycemia, hyponatremia, hypernatremia, hypocalcemia, 
hypomagnesemia, hypokalemia, and hyperkalemia. They represent 9% of all acute 
symptomatic seizures. Though generalized tonic clonic seizures are more common, 
  
focal seizures can also occur. Rapid changes in electrolyte levels are more likely to 
cause seizures than those occurring gradually55.   
Hyponatremia presents with seizures especially when the serum sodium levels 
are below 115mmol/L. The mortality rate in hyponatremia related seizures is very 
high around 50%. Hyponatremia related seizures can be stopped by rapid correction 
in the serum sodium concentration that average only 3 to 7 mEq/L56. In case of 
hypernatremia, seizures are common when there is acute elevation of serum sodium 
concentration to above 160mEq/L and also during rapid correction of hypernatremia. 
Brain shrinkage due to hypernatremia causes rupture of cerebral veins resulting in 
intracerebral and subarachnoid haemorrhages and seizures. Seizures may be the sole 
manifestation in hypocalcemia, occurring in 20-25% of acute cases. Although 
hypercalcemia results in reduced neuronal excitability, it can also cause seizures 
secondary to vasoconstriction and hypertensive encephalopathy57. Neurological 
manifestations occur in hypomagnesemia especially when serum concentrations are 
below 1mEq/L which includes confusion, tremors, seizures, agitation, hyperreflexia, 
tetany and myoclonus.  
 Hypoglycemia can cause focal or generalised seizures in addition to other 
neurological manifestations. The basic underlying mechanism involves reduced ATP, 
impaired Na-K ATPase channel leading to accumulation of sodium ions and 
subsequent cerebral edema. Seizures also manifest in hyperglycemic states especially 
in nonketotic hyperglycemic coma and less frequently in diabetic ketoacidosis58.   
 Renal and hepatic failures are found to be associated with seizures due to the 
accumulation of the toxic compounds or due to the presence of co morbid illness. 
Seizures in renal failure also result due to the complications like malignant 
  
hypertension, intracranial haemorrhage, dialysis disequilibrium syndrome, electrolyte 
and acid base disturbances59. Management of renal failure, control of hypertension 
and correction of electrolytes are needed to prevent the recurrence of seizures60. 
Generalised tonic clonic seizures, status epilepticus and nonconvulsive seizures 
complicate hepatic encephalopathy due to acute or chronic hepatic failure due to toxic 
effects of ammonia in brain61. 
 Seizures due to metabolic abnormalities do not require treatment with 
antiepileptics as long as the underlying cause is rectified. Antiepileptics are usually 
ineffective in stopping the seizure if the metabolic disorder is not corrected.  
 
BRAIN TUMORS 
 More than 30% of patients with brain tumors present as seizures62. Tumors 
mostly cause drug resistant epilepsy especially those in the temporal lobe. Excellent 
seizure control occurs after removal of benign tumors. Benign tumors like 
ganglioneuromas, dysembryoblastic neuroepithelial tumors(DNET) and low grade 
gliomas are commonly associated with seizures. Malignant brain tumors like 
anaplastic astrocytomas and glioblastoma multiforme can present with seizures.  
 Low grade tumors more commonly present with seizures than high grade 
tumors. Brain metastasis from cancers of lung, breast and malignant melanoma can 
present as seizure, although primary could not be identified in one third of the 
patients63. 
TUBERCULOMA 
 Tuberculoma is seen commonly in the developing countries. Around 20 to 30% 
of space occupying lesions in India are tuberculomas64. These develop in the 
parenchyma of brain from “Rich focus” when it does not rupture into subarachnoid 
  
space and continue to grow walled off from the parenchyma and meninges by a thick 
fibrous capsule. Grossly, the lesions are well circumscribed masses with size varying 
from 1 cm to that of a small orange. Occasionally, tuberculomas may develop on the 
surface of the brain leading to a flat adherent mass called 'tuberculoma en plaque'65.  
 Tuberculomas can be seen in the cerebral hemispheres, basal ganglia, 
brainstem and cerebellum. They can also develop in the meninges where it mimics a 
meningioma66. The usual presentations are seizures (60-100%), focal neurological 
deficits (33-68%) and features of raised intracranial tension (56-93%). Pathologically 
these tuberculomas are caseating granuloma which can be solitary or multiple67. 
 CT appearance varies based on the stage of the lesion showing low attenuated 
areas in the early stages of edema and necrosis. When granuloma develops, it is 
visualised as high attenuated area with ring enhancement. These ring enhanced lesions 
contain central calcification surrounded by hypodense region called target sign. MRI 
Brain shows isointense lesion in T1 and T2 weighted sequence in the initial stage68. 
As the lesion advances, it may be either hyper or hypointense in T2, based on the 
relative proportions of cellular infiltrates, macrophages and fibrosis. The granulomas 
appear hyperintense in T2 if it is rich in cellular infiltrates and scanty macrophages 
and less fibrosis, hypointense in T2 if it is rich in macrophages and fibrosis. These 
lesions also enhance with contrast administration and produce solid or ring 
enhancement. Magnetisation transfer technique is another newer method to improve 
the tissue specificity and useful in differentiating tuberculoma from other lesions like 
neurocysticercosis. In tuberculoma, the MT ratio of T2 is hypointense than in 
cysticercosis69. 
 
 
  
NEUROCYSTICERCOSIS: 
 Neurocycticercosis is the most common parasitic disease of the central nervous 
system caused by larval forms (cysticercus cellulosae) of tapeworm, taenia solium. 
These cysts are situated in various areas like intracerebral, subarachnoid, 
intraventricular, spinal cord, and also in various organs, muscles and subcutaneous 
tissues outside the brain.  
The parenchymal cyst tends to remain dormant for several years where it can 
cause minimal or no symptoms. The four stages of parenchymal cysts are  (1) 
vesicular, (2) colloidal, (3)granular-nodular and (4) calcific70. The parasites are 
usually alive in the first two stages, while the last two stages represent the dead 
parasites. Patients become symptomatic only when the larva inside the cyst dies and 
releases its antigen, resulting in an intense inflammatory reaction.  
Seizures are the most common clinical manifestation of neurocycticercosis71. 
Seizures are reported to occur in 70 to 90% of patients with neurocysticercosis72. 
Other symptoms include headache and focal neurological deficits. In a community 
based study done in South India (Vellore district) the prevalence of active epilepsy 
caused by NCC was 1.3 per 1000 population73. The lesions of neurocysticercosis can 
present as single or multiple, although multiple is less common.  The single cyst 
infection (47.7% - 53.4%), is the most common manifestation in Indian 
subcontinent74.  
 Diagnosis is done by clinical, radiological and immunological methods. 
Serological diagnosis is done by complement fixation test, indirect haemagglutination 
tests and ELISA. A newer gold standard test is enzyme linked immunoelectron 
  
transfer blot (ELITB) assay which is done with CSF or serum samples based on seven 
glycoproteins specific to the pathogen.  
Western blot assay have also been developed for diagnosis of NCC75. 
Neuroimaging studies are done using MRI Brain which is used to differentiate various 
stages of the parasite. CT Brain is helpful to detect calcified lesion76. Treatment with 
short course of antiheminthic (albendazole) for 28 days is given along with 
corticosteroids.  
HIV INFECTION: 
 Patients of acquired immunodeficiency disease and other 
immunocompromised states have high risk of seizures either by direct effects of HIV 
virus on CNS or through opportunistic CNS infections77. Common opportunistic 
infections presenting as seizures include tuberculosis, toxoplasmosis, cryptococcosis, 
cytomegalovirus encephalitis and progressive multifocal leukoencephalopathy78. A 
study conducted in a tertiary care centre in India, showed that new onset seizures 
occurred in 5% of HIV patients out of which 26% were focal motor seizures and 8.6% 
were focal seizures with secondary generalization and majority of them were due to 
cerebral toxoplasmosis, followed by cryptococcosis and tuberculoma79.  
 
POST TRAUMATIC SEIZURES: 
 Post traumatic seizures can present as three types, immediate, early and late. 
Seizures that occur within the first 24 hours of trauma are called as immediate, and 
those that occur in the first week are known as early seizures. Late seizures occur 
beyond the first week of trauma. Early seizures contribute to 5% of hospitalised 
  
patients. Among the trauma patients with seizures, about 2-12% of cases were due to 
closed head injury. 
 
  Those injuries with less than 30 minutes of amnesia and without skull 
fractures are considered as mild injuries which are less commonly associated with 
seizures. Moderate head traumas are those in which there are associated skull 
fractures and more than 30 minutes of amnesia. 1-4% of moderate injuries were 
associated with seizures. In severe head trauma with more than 24 hours of amnesia, 
cerebral contusion and intracranial hematoma, seizures are noted in 10-15%. In 
conditions of open head injury and penetrating injuries, seizures are seen in 30-50% 
of patients80.  
 Changes in the brain reflecting the process of epileptogenesis are likely to 
occur in the latent period between the head injury and onset of chronic epilepsy. None 
of the several therapeutic measures tested for prevention of seizures after head injury 
were proven effective.  
 
  
  
MANAGEMENT: 
 
MEDICAL MANAGEMENT: 
 The first line treatment for epilepsy is medical treatment. The goal of treatment 
is a complete seizure free state in the absence of side effects of medications. In around 
70% of patients with epilepsy, seizures are completely or almost completely 
controlled by medications. In another 20 to 25%, the attacks are significantly reduced 
with drugs in number and severity. The choice depends on the type of seizure and 
epilepsy syndrome along with factors like age, sex comorbid conditions and 
interactions with other drugs. Pharmacotherapy is not always necessary after a single 
unprovoked seizure, especially when the risk of recurrence is low.   
 For focal seizures, carbamazepine or phenytoin may be used as first line drugs 
but newer drugs without enzyme induction and better pharmacokinetics have 
supplanted the older ones. Though topiramate and oxcarbazepine are the only drugs 
with official FDA indications, lamotrigine, gabapentin and levitiracetam have 
evidence supporting their use as initial monotherapy. A study by Marson et al has 
shown that lamotrigine was found to be significantly better than carbamazepine, 
gabapentin and topiramate. However, lamotrigine requires slow titration and hence it 
is not an appropriate first choice when rapid onset of action is required. 
Oxcarbazepine and levitiracetam may be the drugs of choice when rapid therapeutic 
effect is required.  
 For all epilepsy indications, treatment is initiated with an AED monotherapy. 
In the absence of urgency, it is preferred to start a low dose antiepileptic and titrate 
slowly. The initial target dose is usually the minimum effective dose demonstrated in 
  
clinical trials which can be titrated gradually until clinical efficacy is established. 
Medication has to be titrated to the highest tolerated dose before it is considered 
ineffective. Replacement monotherapy has to be considered if the initial therapy has 
been completely ineffective or if there is lack of tolerability and the new AED has to 
be added before withdrawing the old agent. Adjunctive therapy should be considered 
based on the pharmacodynamic and pharmacokinetic interactions. All AEDs are 
approved for combination therapy although some combinations have a synergistic 
effect; like lamotrigine and valproate when used together have greater efficacy than 
when used alone. The combination of lamotrigine and levitiracetam is also favoured.  
 
TABLE 1.COMMON ANTIEPILEPTICS USED FOR FOCAL SEIZURES 
DRUGS ADULT DOSE MG/D 
VALPROIC ACID 1000-3000  
PHENYTOIN 300-400 
CARBAMAZEPINE 600-1200 
OXCARBAZEPINE 900-2400 
PHENOBARBITAL 90-200 
LAMOTRIGINE 300-500 
LEVITIRACETAM 500-3000 
TOPIRAMATE 400 
 
Discontinuation of antiepileptic therapy: 
The decision to withdraw medications must balance the potential consequences of 
seizure relapse and the potential benefits of eliminating medication side effects and 
costs on an individual basis. The potential risk factors associated with greater risk of 
recurrence are: 
  
i. presence of EEG abnormality, 
ii. partial seizures,  
iii. longer than 5 years to attain seizure freedom,  
iv. longer duration of active disease,  
v. shorter number of years of remission,  
vi. abnormal psychiatric examination,  
vii. presence of hippocampal atrophy,  
viii. abnormal neurological findings 
ix. older age of seizure onset.  
 Most neurologists require patients to be seizure free for 2 to 4 years before 
discontinuing AEDs, and the drugs are generally discontinued over a 2 to 6 month 
period. A prospective study by Callaghan and colleagues showed that in patients who 
had been seizure free during 2 years of treatment with a single drug, one third of 
patients relapsed after discontinuation of the drug. The relapse rate was higher in 
patients with focal seizures compared to absence and generalized seizures81.  
 
 
 SURGICAL TREATMENT OF EPILEPSY82 
 Surgical excision of epileptic focus which has not responded to prolonged and 
intensive medical treatment is being increasingly used in specialised epilepsy centers. 
It has been proposed that approximately 25% of all patients with epilepsy are 
candidates for surgery. A perspective that may increase surgery is the observation that 
around 60% of patients with focal seizures will respond to a conventional 
  
anticonvulsant and among the remainder only few will respond to the addition of 
second and third line drugs.  
 To determine the location of epileptic focus, careful clinical, EEG and imaging 
findings are needed including long term video/EEG monitoring. Sometimes 
intraparenchymal depth electrodes for intracranial EEG recording may be needed. 
Introduction of functional imaging, magnetoencephalography and specialized EEG 
techniques have supplanted the previous available techniques. 
 The candidates who are most favourable for surgery are those with focal 
seizures that induced altered consciousness and a unilateral temporal lobe focus, in 
whom rates of cure and significant improvement approach 90%. The most common 
surgical approach has been a temporal lobectomy in which lateral temporal cortex is 
resected first and then followed by resection of amygdala and hippocampus. In a 
randomized controlled trail by Wiebe and colleagues, 58% of patients remained 
seizure free for 1 year after temporal lobectomy while only 8% were seizure free on 
medication alone. In patients with clear hippocampal sclerosis, an alternative is 
amygdalohippocampectomy with less risk to language functions and an equal 
outcome.  
 Surgery like callosotomy and hemispherectomy are of value in highly selected 
cases of intractable partial seizures. Removal of entire cortex of one hemisphere along 
with amygdala and hippocampus has been of value in children and some adults in 
severe unilateral disease and intractable contralateral motor seizures with hemiplegia 
like in Rasmussen encephalitis and Sturge weber syndrome.  
 Vagal nerve stimulation is a new technique which has found some favour in 
cases of intractable partial generalizing seizures, where a pacemaker like device is 
  
implanted in the anterior chest wall and electrodes are connected to vagus at left 
carotid bifurcation83. Several trials have demonstrated around 25% reduction in 
frequency of seizures among those resistant to anticonvulsants. However they may be 
considered experimental currently.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
MATERIALS AND METHODS 
STUDY POPULATION:- 
 A total number of 50 patients who are presenting with new onset focal seizures 
during the study period from January 2015 to August 2015 in Thanjavur Medical 
College Hospital, fulfilling the inclusion criteria were taken for the study. 
PLACE OF STUDY: Thanjavur Medical College Hospital, Thanjavur. 
STUDY DESIGN: A hospital based, cross sectional observational study. 
 
INCLUSION CRITERIA:  
1) Patients with new onset focal seizures  
2) Age of onset of seizures >12 years 
 
EXCLUSION CRITERIA: 
1) Age of onset of seizures <12 years 
2) Onset before 12 years but continued to have seizures even after 12 years 
3) Pseudo seizures 
METHODS OF COLLECTION OF DATA: 
 Patients who presented with new onset focal seizures were subjected to 
detailed history, clinical examination and investigations. Patients and the 
attenders/bystanders were enquired in detail about the onset of seizure, progression of 
seizure, presence of aura, automatisms, any associated sensory or autonomic 
symptoms and postictal phenomenon.  Family history of seizures and presence of any 
comorbid illnesses were also noted. Detailed general and systemic examination was 
  
carried out and presence of any residual focal deficits was noted. The following 
investigations were done. 
1) Blood sugar 
2) Blood urea 
3) Serum creatinine 
4) Serum electrolytes- Na+ , K+ , Mg++  
5) Complete hemogram 
6) CT Brain 
7) MRI Brain 
8) EEG 
9) Special investigations like MR spectroscopy in selected cases. 
 
 
 
 
 
 
 
 
 
  
 
OBSERVATION AND RESULTS 
Total number of subjects studied- 50 
The baseline characteristics were observed and the results were shown in tables. 
 
AGE DISTRIBUTION: 
 
TABLE 2: AGE DISTRIBUTION 
AGE IN 
YEARS 
NO. OF 
PATIENTS 
PERCENTAGE 
 
12- 20 5 10% 
21 to 30 18 36% 
31 to 40 6 12% 
41 to 50 3 6% 
51 to 60 10 20% 
61 to 70 8 16% 
TOTAL 50 100% 
 
 
 
 
 
 
  
FIGURE 1: AGE DISTRIBUTION 
 
  
 
In this study, patients of age >12 years were included. The youngest age 
observed was 14 years and oldest was 70 years. The majority of patients belong to age 
group 21-30 years (36%), followed by the age group 51-60 years (20%). About 74% 
of patients were between 2nd -5th decade, and 16% of patients were above 60 years of 
age. 
 
SEX DISTRIBUTION: 
TABLE 3: SEX DISTRIBUTION 
SEX NO.OF PATIENTS 
PERCENTAGE 
 
MALE 30 60% 
FEMALE 20 40% 
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FIGURE 2: SEX DISTRIBUTION 
 
 
 
            In the present study, 30 of 50 patients were males, 20 of 50 patients were 
females. 
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TABLE 4: COMPARISON OF SEX AND AGE IN YEARS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Th
e 
male to female ratio is 1.5:1 in the present study. 
 
 
 
 
 
 
 
AGE IN 
YEARS 
MALES FEMALES TOTAL 
NO. 
% 
among 
males 
NO. 
% 
among 
females 
NO. % 
12-20 4 13.3% 1 5% 5 10% 
21-30 10 33.3% 8 40% 18 36% 
31-40 5 16.7% 1 5% 6 12% 
41-50 2 6.7% 1 5% 3 6% 
51-60 4 13.3% 6 30% 10 20% 
61-70 5 16.7% 3 15% 8 16% 
TOTAL 30 100% 20 100% 50 100% 
  
 
 
 
FIGURE 3:COMPARISON OF SEX AND AGE IN YEARS 
 
 
 
Out of males, the majority belong to the age group 21-30 years (33.3%), and 
out of females also, the majority belong to the age group 21-30years (40%). Mean age 
is 40 years. 
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TYPE OF FOCAL SEIZURES: 
 
TABLE 5: TYPE OF FOCAL SEIZURES 
 
TYPE OF FOCAL SEIZURES NO.OF PATIENTS 
PERCENTAGE 
(100%) 
WITHOUT DYSCOGNITIVE FEATURES 16 32.0 
WITH DYSCOGNITIVE FEATURES 7 14.0 
WITH SECONDARY GENERALIZATION 27 54.0 
 
 
 In this study, the most common type of focal seizures observed was focal 
seizures with secondary generalization (54%) followed by 32% focal seizures without 
dyscognitive features and 14% focal seizures with dyscognitve features. Out of 16 
patients with focal seizures without dyscogntive features 2 patients had epilepsia 
partialis continua.  
 
 
 
 
 
 
 
 
  
FIGURE 4: DISTRIBUTION OF TYPE OF SEIZURES 
 
 
 
AURA: 
  Among the 50 patients, 16 patients(32%) had symptoms suggestive of aura, out 
of which 8 patients had somatosensory aura, 5 patients had autonomic aura, 2 patients 
had emotional aura in the form of fear 1 patient had cephalic sensation in the form of 
pressure on the head and lightheadedness. 
 
 
AUTOMATISM: 
 Among 7 patients with focal seizures with dyscognitive features, 3 patients had 
automatism.  
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COMORBID CONDITIONS: 
 The various comorbid conditions observed among the patients of new onset 
focal seizures were hypertension, diabetes mellitus, chronic kidney disease, 
pulmonary tuberculosis. Majority of the patients had previous stroke followed by 
diabetes mellitus and chronic kidney disease. 5 patients had diabetes, hypertension 
and chronic kidney disease. One patient with tuberculoma was found to have 
associated pulmonary tuberculosis and another patient with tuberculoma was 
diagnosed with immunodeficiency.  
 
TABLE 6: DISTRIBUTION OF CO MORBID CONDITIONS 
 
COMORBID 
CONDITIONS 
NO.OF 
PATIENTS 
Hyperrtension 5 
Old CVA 11 
Diabetes mellitus 9 
Chronic kidney disease 3 
Hyperhomocystinemia 1 
Immunodeficient state 1 
Postpartum 1 
Pulmonary tuberculosis 1 
Carcinoma breast  1 
 
 
 
 
 
  
FIGURE 5: DISTRIBUTION OF COMORBID CONDITIONS 
  
 
IMAGING STUDIES: 
 CT Brain and MRI Brain were taken for the patients presenting with focal 
seizures. CT brain showed abnormality in 35(70%) patients.  In case of old 
cerebrovascular diseases, CT Brain showed gliotic changes suggestive of old vascular 
etiology in 11 patients. Calcified granuloma with surrounding edema is seen in 4 
patients, hypodense lesions present in 5 patients pointing to a diagnosis of 
tuberculoma with MRI. MR spectroscopy was done in 2 patients to differentiate the 
tuberculoma lesions from neurocysticercosis which showed decreased choline peak in 
tuberculoma patients.  
 CT brain also showed single calcified lesions in 3 patients, hypodense lesion 
with calcification in 2 patients and multiple ring enhancing lesions involving both 
cerebral hemispheres suggestive of neurocysticercosis. Calcified granuloma with no 
active lesion was found in 4 patients for which no further etiology could be found as 
they were healed lesions.  
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  Those patients in whom cerebral venous thrombosis was suspected, MR 
angiogram and MR venogram were taken which showed thrombosis in superior 
sagittal sinus in 1 case and thrombosis in transverse sinus in other case.   
  CT Brain and MRI Brain also revealed tumors namely glioma in one 
patient and secondaries in brain in other patient. In a patient with post traumatic 
seizure, hemorrhagic contusion in left temporoparietal region was noted. Both CT 
brain and MRI brain was found to be normal in 14 patients out of which 7 patients 
had metabolic causes and 7 patients no cause could be found with the available 
investigations. 
 
TABLE 7. CT BRAIN ABNORMALITIES 
 
CT BRAIN NO.OF PATIENTS PERCENTAGE 
NORMAL 15 30% 
ABNORMAL 35 70% 
TOTAL 50 100% 
 
 
 
TABLE 8. CORRELATION OF CT BRAIN WITH MRI BRAIN 
 
MRI BRAIN 
CT BRAIN 
P VALUE Normal Abnormal Total 
(n=15) (100%) (n=35) (100%) (n=50) (100%) 
Normal 14 93.3% 0 .0% 14 28.0% 
.000 
Abnormal 1 6.7% 35 100.0% 36 72.0% 
 
  
In this study, statistical significance with the p value of < 0.05 was obtained 
with the imaging findings, indicating that the MRI Brain was found to be superior to 
CT Brain in detecting the abnormal findings. 
 
 
EEG: 
 Electroencephalography was done in all 50 patients, out of which 26 (52%) of 
them had abnormal EEG recordings, and 24 patients(48%) patients had normal EEG 
recordings. Most of the EEG was taken during the interictal period. 
 
ETIOLOGY OF SEIZURES:    
TABLE 9. DISTRIBUTION OF ETIOLOGY 
 
ETIOLOGY NO.OF PATIENTS PERCENTAGE 
Calcified Granuloma 4 8% 
CVT 2 4% 
Idiopathic 7 14% 
Metabolic 7 14% 
NCC 6 12% 
Post stroke gliosis 11 22% 
Post Traumatic 1 2% 
Tuberculoma 10 20% 
Tumor 2 4% 
Total 50 100% 
 
 
 
 
 
  
 
 
FIGURE 6: DISTRIBUTION OF ETIOLOGY 
 
 
  
The commonest cause was due to cerebrovascular diseases causing poststroke gliosis 
(22%) followed by tuberculoma (20%), metabolic (14%),  idiopathic (14%), 
neurocysticercosis (12%), calcified granuloma (8%) cerebral venous thrombosis(4%) 
and tumor(4%) and posttraumatic (2%).  
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FIGURE 7: DISTRIBUTION OF METABOLIC CAUSES 
 
 
 
 Among the metabolic causes, 4 patients had hyperglycemia, 2 patients had 
uremia and 3 patients had hyponatremia. 
 
 
ETIOLOGY ACCORDING TO SEX DISTRIBUTION: 
MALES:  
Total number of males: 30 
 The commonest etiology of focal seizures in males are neuroinfections which 
includes tuberculoma and neurocysticercosis accounting for 33.3% followed by 
poststroke gliosis(20%) followed by idiopathic(16.7%), metabolic(13.3%), calcified 
granuloma(10%). 
 The less common etiologies include CVT(3.3%) and posttraumatic (3.3%).  
 
Hyperglycemia
Hyponatremia
Uremia
  
FEMALES: 
  Total number of cases: 20 
The commonest etiology in females is also Neuroinfections (30%), followed 
by poststroke gliosis(25%), metabolic (15%). 
The less common etiologies are idiopathic (10%), tumors(10%), calcified 
granuloma(5%),CVT (5%). 
 
 
 
TABLE 10:ASSOCIATION OF SEX WITH ETIOLOGY 
 
ETIOLOGY 
SEX  
P VALUE MALE FEMALE TOTAL 
(n=30) (100%) (n=20) (100%) (n=50) (100%) 
Calcified 
Granuloma 
3 10.0% 1 5.0% 4 8.0% 
.781>0.05 
Not 
Significant 
CVT 1 3.3% 1 5.0% 2 4.0% 
Idiopathic 5 16.7% 2 10.0% 7 14.0% 
Metabolic 4 13.3% 3 15.0% 7 14.0% 
NCC 4 13.3% 2 10.0% 6 12.0% 
Post stroke gliosis 6 20.0% 5 25.0% 11 22.0% 
Post Traumatic 1 3.3% 0 .0% 1 2.0% 
Tuberculoma 6 20.0% 4 20.0% 10 20.0% 
Tumor 0 .0% 2 10.0% 2 4.0% 
 
 Statistical significance was found for association of sex and etiology of seizure 
with Chi square test and there was no significant association found between etiology 
of seizure and sex of the patients. (p value > 0.05) 
 
 
  
ETIOLOGY ACCORDING TO AGE DISTRIBUTION: 
Most common etiology among 12-20 years is neuroinfections both 
tuberculoma and neurocysticercosis together (60%), followed by idiopathic (40%). 
Among 21-30 years, most common etiology is neuroinfections ,tuberculoma (33.3%), 
followed by neurocysticercosis (30.4%). Among age group 31-40 years, idiopathic 
(50%) followed by tuberculoma (33.3%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
TABLE 11. ETIOLOGY ACCORDING TO AGE GROUP 
 
 
 
S.NO ETIOLOGY 12-20 21-30  31-40 41-50 51-60 61-70 
Total 
n(100%) 
1. 
Calcified 
granuloma 
0 3 0 1 0 0 4(8%) 
2. CVT 0 2 0 0 0 0 2(4%) 
3. Idiopathic 2 2 3 0 0 0 7(14%) 
4. Metabolic 0 0 0 0 0 7 7(14%) 
5. NCC 1 3 1 1 0 0 6(12%) 
6. Poststroke gliosis 0 1 0 1 8 1 11(22%) 
7. Post traumatic 0 1 0 0 0 0 1(2%) 
8. Tuberculoma 2 6 2 0 0 0 10(20%) 
9. Tumor 0 0 0 0 2 0 2(4%) 
 
TOTAL 
5 
(10%) 
18 
(36%) 
6 
(12%) 
3 (6%) 
10 
(20%) 
8 
(16%) 
50(100%) 
 
 
 In the age group 41-50 years, calcified granuloma, neurocysticercosis and 
poststroke gliosis each contributed 33.3%.   
 
 
 
 
 
 
 
 
 
  
 
 
 
FIGURE 8. ETIOLOGY ACCORDING TO AGE DISTRIBUTION 
 
 
 
 
 
Among 51-60 years, 80% was due to poststroke gliosis followed by 
tumors(20%). In the age group 61-70 years, 87.5% cases was due to metabolic 
etiology follwed by poststroke gliosis(12.5%). 
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TABLE 12. CORRELATION OF CT BRAIN FINDINGS WITH ETIOLOGY 
ETIOLOGY 
CT BRAIN FINDINGS 
P VALUE Normal Abnormal Total 
(n=15) (100%) (n=35) 100.0% 50 100.0% 
Calcified Granuloma 0 .0% 4 11.4% 4 8.0% 
.000<0.05 
Significant 
CVT 1 6.7% 1 2.9% 2 4.0% 
Idiopathic 7 46.7% 0 .0% 7 14.0% 
Metabolic 7 46.7% 0 .0% 7 14.0% 
NCC 0 .0% 6 17.1% 6 12.0% 
Post stroke gliosis 0 .0% 11 31.4% 11 22.0% 
Post Traumatic 0 .0% 1 2.9% 1 2.0% 
Tuberculoma 0 .0% 10 28.6% 10 20.0% 
Tumor 0 .0% 2 5.7% 2 4.0% 
 
The majority of cerebrovascular diseases (31.4%) and neuroinfections (45.7%) 
showed abnormal CT Brain findings when compared to other etiologies. The 
metabolic causes (46.7%) had normal CT Brain imaging. This was statistically 
significant (p value <0.05). 
 
ETIOLOGY AND TYPE OF SEIZURES 
 The most common seizure type is focal seizures with secondary generalization 
followed by focal seizures without dyscognitive features and focal seizures with 
dyscognitive features.  
 Among focal seizures with dyscognitive features, around 71.4% was idiopathic 
and 28.6% was due to tuberculoma.  
 Among seizures without dyscognitive features, 31.3% was due to tuberculoma 
and 25% was due to poststroke gliosis followed by other causes..   
  
 Among focal seizures with secondary generalization, 25.9% was due to 
poststroke gliosis. 
 
 
 
TABLE 13: ASSOCIATION OF ETIOLOGY WITH TYPE OF SEIZURES 
ETIOLOG
Y 
TYPES OF FOCAL SEIZURE 
P 
VALUE 
With 
dyscognitive 
features 
Without 
dyscognitive 
features 
With 
secondary 
generalizatio
n 
TOTAL 
(n=7
) 
(100%
) 
(n=16
) 
(100%
) 
(n=27
) 
(100%
) 
(n=50
) 
(100%
) 
Calcified 
Granuloma 
0 .0% 3 18.8% 1 3.7% 4 8.0% 
.006<0.05 
Significa
nt 
CVT 0 .0% 0 .0% 2 7.4% 2 4.0% 
Idiopathic 5 71.4% 0 .0% 2 7.4% 7 14.0% 
Metabolic 0 .0% 2 12.5% 5 18.5% 7 14.0% 
NCC 0 .0% 2 12.5% 4 14.8% 6 12.0% 
Post stroke 
gliosis 
0 .0% 4 25.0% 7 25.9% 11 22.0% 
Post 
Traumatic 
0 .0% 0 .0% 1 3.7% 1 2.0% 
Tuberculom
a 
2 28.6% 5 31.3% 3 11.1% 10 20.0% 
Tumor 0 .0% 0 .0% 2 7.4% 2 4.0% 
 
There is significant association between type of seizures with the etiology of 
seizures with the p value of <0.05. 
 
 
 
 
 
 
  
FIGURE 9: ETIOLOGY AND TYPE OF SEIZURES 
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DISCUSSION 
 
           In our study, 50 cases of new onset focal seizures were included as per the 
inclusion and exclusion criteria and the observations were compared with similar 
other studies. 
 
Age and sex distribution: 
 In the present study, out of 50 patients, 30 were males and 20 were females and 
the male to female ratio is M: F = 1.5:1. This was similar to a study done by 
AMARAVATHI et al (2015) in Hyderabad, India84. In a study by DILLI RAM 
KAFLE (2013) the male to female ratio was 1.3:185. Among both males and females, 
most of them belong to the age group 21 to 30 years. 
  In this study, majority of the patients belong to the age group 21-30 years 
(36%), and 74% were in the age group 2nd-5th decade. In the study by 
AMARAVATHI et al, majority (26%) patients were in the age group 28- 37 years 
followed by 18% each in 18 to 27 years and 57-68 years. In a study by DILLI RAM 
KAFLE (2013), the majority 38% belonged to age group less than 20 years, probably 
because in the present study only new onset seizures were included.  
 
Type of focal seizures: 
  In the present study, focal seizures with secondary genreralization was the 
most common type (54%) followed by focal seizures with and without dyscognitive 
features. This was similar to the study by DILLI RAM KAFLE (2013), where focal 
seizures with secondary generalization was seen in 43% followed by focal seizures 
  
with and without dyscognitive features 29% each, while in AMARAVATHI et 
al(2015), focal seizure without dyscognitive features was the most common (54%). 
5% patients had epilepsia partialis continua in this study. In AMARAVATHI et al 
(2015), 12% of pateints had epilepsia partialis continua. In this study, 16 patients 
(32%) had symptoms of aura and somatosensory aura was most commonly present, 
while in AMARAVATHY et al, aura was reported in 48%. 
 
Etiology of seizures: 
 In the present study, the majority of cases 22% were due to poststroke gliosis. 
This was similar to AMARAVATHY et al (2015) which reported 38% of cases due to 
poststroke gliosis. The study by DILLI RAM KAFLE (2013) (55%) showed calcified 
granuloma as the most common cause, while cerebral infarction was the next common 
contributing 17%. Calcified granuloma constitutes around 8% of cases in the present 
study. 
  
 Among the neuroinfections, tuberculoma constitutes 20% while 
neurocysticercosis accounts for 12%. In AMARAVATHI et al (2015) study, 
tuberculoma was reported around 10% while neurocysticercosis was around 14%. 
While in DILLI RAM KAFLE (2013), tuberculoma constituted 8%. In a study by 
WASHIMKAR et al (1996), tuberculoma constituted 65.9% of cases of partial 
seizures86.  
 Metabolic cause of seizures constitutes 14% in our study out of which majority 
are due to hyperglycemia (57%) followed by uremia and hyponatremia. In a study by 
  
NARAYANAN JT and MURTHY JMK (2007) hyponatremia was the most common 
metabolic cause of seizures (71.4%)87. 
 Tumors were observed in 6% of cases in the study by AMARAVATHI  et al 
(2015). In the present study, tumor constitutes 4% of cases.  
 Seizures are found to be idiopathic in 14% in the present study. In 
AMARAVATHI et al (2015), 10% were found to be idiopathic. DILLI RAM KAFLE 
reported mesial temporal sclerosis in 4% while no case of mesial temporal sclerosis is 
diagnosed in the present study.  
 
Etiology according to age: 
 In our study, majority of poststroke gliosis occured in 51 to 60 years, while 
neuroinfections mainly tuberculomas and neurocysticercosis are the major causes in 
21 to 30 years age group. This was similar to a study by HAUSER et al, where 50% 
of neuroinfections were observed in 2nd-3rd decades and metabolic causes were 
common in the age group above 40 years88.  
 
Imaging findings: 
 EEG taken during interictal period showed abnormality in 52% of patients and 
48% had normal EEG findings.  
 CT brain is found to be abnormal in 70% of patients. The most common lesion 
in CT brain was gliosis due to old infarct followed by hypodense lesion with edema. 
In DILLI RAM KAFLE, 74% had imaging abnormality while in AMARAVATHY et 
al (2015), 86% had imaging abnormality. In a study by RAVINDRA KUMAR GARG 
et al (1998), 71.4 % had abnormal imaging89. In a study by WADIA et al, 68% had 
  
CT abnormalities and the most common lesion was a ring ehancing lesion90.  The 
majority of cerebrovascular diseases (22%) and neuroinfections (32%) showed 
abnormal CT Brain findings when compared to other etiologies like metabolic causes 
with a significant p value of <0.05.  
  
  
 It was very difficult to differentiate between between neurocysticercosis and 
tuberculoma with CT brain alone. MRI brain was taken in all these patients. Chest x 
ray was also done in all suspected cases of tuberculoma. Overall, MRI Brain was 
found to be superior to CT Brain in detecting abnormal findings (p <0.05).  
 In this study, despite careful investigations, 10% were diagnosed with 
idiopathic epilepsy. More sensitive scanning techniques may help to further sort this 
group of idiopathic epilepsy into other categories.  
  
  
 
 
TABLE 14: COMPARISON OF ETIOLOGICAL SPECTRUM OF THE 
PRESENT STUDY WITH OTHER STUDIES 
ETIOLOGY 
AMARAVATHY 
et al (2015) 
DILLI RAM 
KAFLE 
(2013) 
PRESENT 
STUDY 
Tuberculoma 10% 6% 20% 
NCC 14%  12% 
Calcified granuloma 14% 55% 8% 
Post stroke gliosis 38% 17% 22% 
Metabolic   14% 
Idiopathic 10% 12% 14% 
Tumors 6% 4% 4% 
CVT   4% 
Posttraumatic  2% 2% 
Brain abscess 4%   
Meningitis 4%   
Mesial temporal sclerosis  4%  
 
 All patients were started on antiepileptic drugs. Most of the patients had 
adequate control of seizures with a single antiepileptic drug. For patients with 
tuberculoma, Antituberculous therapy was started.  
 
 
 
 
  
 
Follow up scan was advised after 12 weeks to look for regression of lesions. 
For patients with neurocysticercosis, Albendazole was given for 28 days along with 
steroids. Metabolic factors were corrected in those with metabolic etiology. Patients 
with brain tumors were referred to neurosurgery.   
 
 
  
  
 
SUMMARY 
 
This study was the cross sectional observational study carried out with 50 
patients of new onset focal seizures admitted in Thanjavur Medical College Hospital 
fulfilling the inclusion and exclusion criteria.  
 Of the total 50 patients, 60% were males and 20% were females, with the ratio 
of M: F=1.5:1. Majority of the patients belong to the age group 21-30 years (36%), 
and 74% were in the age group 2nd-5th decade. 
 Focal seizures with secondary genreralization was the most common type 
(54%) followed by focal seizures without dyscognitive features (32%) and  focal 
seizures with dyscognitve features (14%). Two patients had epilepsia partialis 
continua. 16 patients (32%) had symptoms of aura. 
  Old cerebrovascular disease was seen in 22%, diabetes mellitus in 18%, 
hypertension in 10%, chronic kidney disease in 6%.  
 The commonest cause was due to cerebrovascular diseases causing poststroke 
gliosis (22%) followed by tuberculoma (20%), metabolic (14%),  idiopathic (14%), 
neurocysticercosis (12%), calcified granuloma (8%) cerebral venous thrombosis(4%), 
tumor(4%) and posttraumatic (2%).  
  
 
 
 
  
CONCLUSION 
 
The following conclusions were made from the present study,  
 Majority of focal seizures were noted in the age group 2nd to 5th decade with 
male preponderance. 
 Most of the focal seizures were focal seizures with secondary generalization 
(54%) 
 The spectrum of etiology varies which include old cerebrovascular diseases, 
Neuroinfections, metabolic causes, tumors,  and idiopathic. 
 In younger age group less than 30 years, neuroinfections were the most 
common cause. 
 In age more than 50 years, metabolic causes and cerebrovascular diseases 
predominate.  
 Hence, in all cases of new onset focal seizures, complete evaluation is required 
to identify the etiology and hence to initiate proper treatment, thereby the 
morbidity and mortality in the community can be reduced.  
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I __________________________________________ hereby give consent 
to participate in the study conducted by DR. REVATHY.V,  Post graduate in 
the Department of General Medicine, Thanjavur Medical College & Hospital, 
Thanjavur – 613004 and to use my personal clinical data and result of 
investigation for the purpose of analysis and to study the nature of disease. I 
also give consent for further investigations.  
 
 
Place : 
Date : 
 
Signature of participant 
 
 
 
 
 
 
 
 
  
A STUDY OF CLINICAL AND ETIOLOGICAL PROFILE            
 OF FOCAL SEIZURES 
PROFORMA 
 
 
 Name:       D.O.A: 
 Age:        D.O.D: 
 Sex:        Male/Female     Address: 
 Occupation: 
 
CHIEF COMPLAINTS: 
 
 
 HISTORY OF PRESENTING ILLNESS: 
1. Convulsions: 
 
a) Duration: 
 
b) No. of episodes: 
 
c) Type of focal seizure: 
 
d) Aura:      Yes / No 
 
e) Type of aura:  
 
f) Automatism:     Yes/No 
 
g) Loss of consciousness:  Yes / No 
 
h) Tongue bite:    Yes / No 
 
i) Autonomic symptoms:   
 Frothing / Sweating / Salivation/ Urination/ Defecation 
  
j) Postictal state: Confusion / Amnesia / Paralysis  
 
 
2. Other associated complaints: 
a. Fever: 
b. Headache: 
c. Nausea/ vomiting: 
  
d. Focal deficits: 
e. Others: 
PAST HISTORY: 
 Previous history of seizures: yes / no 
 
 H/o  stroke / infections / trauma / recent delivery: 
 
 H/o  ht / dm / tb / rheumatic heart disease/ psychiatric disorder 
 
 Others: 
FAMILY HISTORY: 
 Any similar complaints in other family members 
 
 Comorbid illness:   yes / no 
PERSONAL HISTORY: 
 Habits-  
o Smoking:  yes/ no.  if yes, duration: 
 
o Alcohol:   yes/ no.  if yes, duration: 
 
o Tobacco chewing: yes/ no 
 
o Drug abuse:  yes/ no.  if yes, drug: 
 
o Exposure to STDs: yes/ no. 
 
EXAMINATION OF THE PATIENT 
 
GENERAL EXAMINATION: 
 Build and nourishment: 
 
 Pallor / icterus/ clubbing / cyanosis/ pedal edema / lymphadenopathy 
 
 Any neurocutaneous markers:  
 
VITAL SIGNS: 
 Pulse:        RR: 
 BP:        Temp: 
 
 
  
CENTRAL NERVOUS SYSTEM EXAMINATION: 
 
A) Higher mental functions 
a. Consciousness: 
b. Orientation to : time/ place / person 
c. Appearance and behaviour: 
d. Attention: 
e. Vigilance: 
f. Language: 
g. Memory 
h. Intelligence 
 
B) Cranial nerves examination:  Right   Left 
 
CN I:   Sense of smell 
 
CN II:  Visual acuity 
  Field of vision: 
                Colour vision: 
                Fundus: 
 
CN III, IV,  
 VI:  Ptosis:  present / absent 
                Extraocular movements: 
  Pupils- size, shape: 
   Light reflex:           direct / indirect 
 
CN V:           Motor: 
  Sensory: 
  Reflexes: 
 
CN VII: Motor: 
  Taste sensation: 
 
CN VIII: Rinnes test: 
  Webers test: 
 
CN IX: 
CN X:  Uvula  
  Palatal reflex 
  Pharyngeal reflex: 
 
  
CN XII: Sternocleidomastoid: 
  Trapezius: 
 
CN XII: Tongue movements 
  Wasting/Fasciculations 
        
 
C) Motor system:     Right  Left 
  Bulk: 
  Tone 
  Power 
   Shoulder 
   Elbow 
   Wrist 
   Hand grip 
   Hip: 
   Knee: 
   Ankle: 
  Reflexes: 
   Superficical :   Abdominal 
         Cremasteric 
         Plantar 
   Deep : Biceps 
     Triceps 
     Supinator 
     Knee 
     Ankle 
     Jaw jerk 
           Any abnormal movements: 
    
  
D)  Sensory system: 
   Touch 
   Pain 
   Temperature 
   Vibration 
   Joint position sense 
   Cortical sensation:  
    Stereognosis 
    Tactile localisation 
    Two point discrimination 
    Romberg’s sign 
E) Cerebellar signs: 
 
F) Gait: 
 
  
G) Signs of meningeal irritation: 
 
H) Spine and Cranium: 
 
OTHER SYSTEMS: 
 Cardiovascular system: 
 Respiratory system: 
 Abdomen: 
  
INVESTIGATIONS: 
1) Urine 
Albumin 
Sugar 
Deposits 
Others 
2) Blood sugar: 
3) Blood urea: 
4) Serum creatinine: 
5) Serum electrolytes: 
a. Sodium 
b. Potassium 
6) Complete hemogram 
a. Hb%:    e.   Platelets: 
b. TC:    f.   PCV: 
c. DC:    g.   ESR: 
d. RBC:     
 
7) VCTC: 
 
8) ECG: 
 
9) Chest X ray: 
 
10) CT  brain: 
 
11) MRI brain: 
 
12) EEG: 
 
13) Others: 
 
 
  
 MASTER CHART 
S.NO. NAME AGE SEX TYPE OF FOCAL SEIZURE AURA TYPE OF AURA AUTOMATISM COMORBIDITY EEG CT BRAIN MRI BRAIN ETIOLOGY
ETIOLOGY OF METABOLIC 
SEIZURES
1 THENMOZHI 24 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES YES SOMATOSENSORY NORMAL ABNORMAL ABNORMAL TUBERCULOMA
2 LAKSHMI 60 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO CA BREAST ABNORMAL ABNORMAL ABNORMAL TUMOR
3 VALARMATHY 29 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES
CEPHALIC 
SENSATION NORMAL NORMAL NORMAL IDIOPATHIC
4 RAJENDRAN 25 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
5 VIJAY 18 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
6 MURUGANANDHAM 63 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO SHT, CVA ABNORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
7 SHANMUGAVALLI 56 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO CVA NORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
8 ARASAN 30 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES YES AUTONOMIC NORMAL ABNORMAL ABNORMAL NCC
9 LAKSHMIKANDHAN 70 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO DM NORMAL NORMAL NORMAL METABOLIC HYPERGYCEMIA
10 JEGANNATHAN 40 M
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES YES AUTONOMIC YES NORMAL NORMAL NORMAL IDIOPATHIC
11 JAGADAMBAL 65 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO DM NORMAL NORMAL NORMAL METABOLIC HYPERGYCEMIA
12 REVATHY 26 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES YES SOMATOSENSORY ABNORMAL ABNORMAL ABNORMAL CALCIFIED GRANULOMA
13 SATISH KUMAR 21 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO HYPERHOMOCYSTINEMIA NORMAL NORMAL ABNORMAL CVT
14 DURAIRAJ 27 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO NORMAL ABNORMAL ABNORMAL CALCIFIED GRANULOMA
15 SHEIK BABU 35 M
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES YES EMOTIONAL AURA YES ABNORMAL NORMAL NORMAL IDIOPATHIC  
  
16 MAHADEVAN 14 M
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES NO NO NORMAL NORMAL NORMAL IDIOPATHIC
17 MUTHUKUMAR 25 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO ABNORMAL ABNORMAL ABNORMAL POSTTRAUMATIC
18 SULOCHANA 68 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO DM, CKD NORMAL NORMAL NORMAL METABOLIC UREMIA
19 MUTHAIYAN 30 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO ABNORMAL ABNORMAL ABNORMAL CALCIFIED GRANULOMA
20 THENNARASI 56 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO ABNORMAL ABNORMAL ABNORMAL TUMOR
21 MUTHULAKSHMI 52 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO SHT, DM, CVA NORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
22 RAVI 21 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES SOMATOSENSORY PT ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
23 AJITH 20 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO NORMAL ABNORMAL ABNORMAL TUBERCULOMA
24 MURUGAN 42 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES YES AUTONOMIC ABNORMAL ABNORMAL ABNORMAL CALCIFIED GRANULOMA
25 PAPPA 50 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO CVA NORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
26 ARIVAZHAGAN 28 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES AUTONOMIC ABNORMAL ABNORMAL ABNORMAL NCC
27 KRISHNAMOORTHY 65 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO DM, CKD NORMAL NORMAL NORMAL METABOLIC HYPONATREMIA
28 RAJATHI 60 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES SOMATOSENSORY SHT, CVA NORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
29 KUNJAMMAL 67 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO DM NORMAL NORMAL NORMAL METABOLIC HYPERGLYCEMIA
30 POTTU 31 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
 
  
31 NADHIYA 25 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO POSTPARTUM NORMAL ABNORMAL ABNORMAL CVT
32 CHELLAPPA 26 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
33 JAYABAL 32 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO NORMAL NORMAL NORMAL IDIOPATHIC
34 VANITHA 16 M
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES YES EOMTIONAL AURA NO ABNORMAL NORMAL NORMAL IDIOPATHIC
35 ARUN KUMAR 28 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES SOMATOSENSORY ABNORMAL ABNORMAL ABNORMAL NCC
36 PITCHAIYAN 70 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO DM NORMAL NORMAL NORMAL METABOLIC HYPERGLYCEMIA
37 RAMAN 32 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES AUTONOMIC IMMUNODEFICIENT STATE ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
38 ANJALAI 56 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION YES SOMATOSENSORY CVA ABNORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
39 MANIMEGALAI 26 F
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES NO NO NORMAL NORMAL NORMAL IDIOPATHIC
40 RANI 59 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO CVA ABNORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
41 SOWMYA 22 F
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES NO YES ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
42 VADIVEL 58 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO CVA ABNORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
43 MURUGANANDHAM 55 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO CVA ABNORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
44 KALPANA 32 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO NORMAL ABNORMAL ABNORMAL NCC
45 PITHCHAIYAMMAL 60 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO SHT, DM, CVA NORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
46 BABU 56 M
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES YES SOMATOSENSORY SHT, CVA NORMAL ABNORMAL ABNORMAL POSTSTROKE GLIOSIS
47 KANNAYIRAM 68 M
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO DM, CKD NORMAL NORMAL NORMAL METABOLIC UREMIA
48 RAJESHWARI 45 F
FOCAL SEIZURES WITH 
SECONDARY GENERALIZATION NO NORMAL ABNORMAL ABNORMAL NCC
49 ANBARASI 28 F
FOCAL SEIZURES WITH 
DYSCOGNITIVE FEATURES YES SOMATOSENSORY NO ABNORMAL ABNORMAL ABNORMAL TUBERCULOMA
50 PRIYANGA 18 F
FOCAL SEIZURES WITHOUT 
DYSCOGNITIVE FEATURES NO ABNORMAL ABNORMAL ABNORMAL NCC
  
 
